Pharmacopeia, Inc. (“Pharmacopeia” or the “Company”) is a leader in enabling
science and technology that accelerates and improves the drug discovery and
chemical development processes. Our software segment is operated through
Accelrys Inc. (“Accelrys”), a wholly-owned subsidiary of the Company which
develops and commercializes molecular modeling, simulation, informatics, and
decision support software for the life sciences and materials research markets.
Our Drug Discovery segment is operated through Pharmacopeia Drug Discovery, Inc.
(“PDD”), a wholly-owned subsidiary of the Company which integrates proprietary
small molecule combinatorial and medicinal chemistry, high-throughput screening,
in-vitro pharmacology, computational methods and informatics to discover and
optimize lead compounds. Pharmacopeia is headquartered in Princeton, New Jersey
and was incorporated in Delaware in 1993. Our internet address is
www.pharmacopeia.com.  ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2004%2f03%2f10%2f0001104659-04-006904.html#FIS_BUSINESS"